These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 17704747

  • 1. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S, Xu Z, Qian X, Ding Y, Yu L, Liu B.
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [Abstract] [Full Text] [Related]

  • 2. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
    Shen SN, Xu Z, Qian XP, Ding YT, Yu LX, Liu BR.
    Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
    [Abstract] [Full Text] [Related]

  • 3. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
    Van den Bosch GA, Ponsaerts P, Nijs G, Lenjou M, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.
    Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA, Van Gulck E, Ponsaerts P, Nijs G, Lenjou M, Apers L, Kint I, Heyndrickx L, Vanham G, Van Bockstaele DR, Berneman ZN, Van Tendeloo VF.
    J Immunother; 2006 Mar; 29(5):512-23. PubMed ID: 16971807
    [Abstract] [Full Text] [Related]

  • 5. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D.
    Eur J Immunol; 1995 Oct; 25(10):2972-7. PubMed ID: 7589100
    [Abstract] [Full Text] [Related]

  • 6. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
    Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF.
    Clin Cancer Res; 2004 Oct 15; 10(20):6946-55. PubMed ID: 15501973
    [Abstract] [Full Text] [Related]

  • 7. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
    Wan Y, Ma X, Li X, Yi J.
    Med Hypotheses; 2009 Nov 15; 73(5):835-7. PubMed ID: 19632790
    [Abstract] [Full Text] [Related]

  • 8. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK, Nguyen Pham TN, Nguyen Hoang TM, Kang HK, Jin CJ, Nam JH, Chung SY, Choi SJ, Yang DH, Kim YK, Chung IJ, Kim HJ, Lee JJ.
    Ann Hematol; 2009 Nov 15; 88(11):1113-23. PubMed ID: 19277657
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.
    Ranheim EA, Kipps TJ.
    Cell Immunol; 1995 Apr 01; 161(2):226-35. PubMed ID: 7535196
    [Abstract] [Full Text] [Related]

  • 10. IL-4-producing CD8+ T cell clones can provide B cell help.
    Cronin DC, Stack R, Fitch FW.
    J Immunol; 1995 Apr 01; 154(7):3118-27. PubMed ID: 7897202
    [Abstract] [Full Text] [Related]

  • 11. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.
    Hum Immunol; 2007 May 01; 68(5):334-41. PubMed ID: 17462500
    [Abstract] [Full Text] [Related]

  • 12. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J, Chen M, Peng ML, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar 01; 13(3):198-201. PubMed ID: 15760555
    [Abstract] [Full Text] [Related]

  • 13. Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.
    Zhang L, Zhang H, Liu W, Wang H, Jia J, Si X, Ren J.
    Cell Immunol; 2005 Nov 01; 238(1):61-6. PubMed ID: 16472793
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Sun H, Li BZ, Ding CN, Zhou F.
    Auris Nasus Larynx; 2006 Dec 01; 33(4):441-6. PubMed ID: 16934422
    [Abstract] [Full Text] [Related]

  • 15. Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.
    Macaulay AE, DeKruyff RH, Goodnow CC, Umetsu DT.
    J Immunol; 1997 May 01; 158(9):4171-9. PubMed ID: 9126977
    [Abstract] [Full Text] [Related]

  • 16. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
    Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, Tan KC, Lim SG, Bertoletti A.
    Gastroenterology; 2009 Aug 01; 137(2):682-90. PubMed ID: 19394336
    [Abstract] [Full Text] [Related]

  • 17. Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.
    Zhang HM, Zhang LW, Ren J, Fan L, Si XM, Liu WC.
    Cell Immunol; 2006 Feb 01; 239(2):144-50. PubMed ID: 16814271
    [Abstract] [Full Text] [Related]

  • 18. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 01; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 19. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L, Perin A, Siviero M, Piazza F, Facco M, Gurrieri C, Galvan S, Adami F, Agostini C, Pizzolo G, Zambello R, Semenzato G.
    Cancer; 2000 Sep 15; 89(6):1259-68. PubMed ID: 11002221
    [Abstract] [Full Text] [Related]

  • 20. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
    Onaitis MW, Kalady MF, Emani S, Abdel-Wahab Z, Tyler DS, Pruitt SK.
    Surgery; 2003 Aug 15; 134(2):300-5. PubMed ID: 12947333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.